Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2026-01-02 @ 2:37 AM
Study NCT ID:
NCT05511350
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2022-10-18
First Post:
2022-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001
Sponsor:
I-Mab Biopharma US Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TJ210001STM103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None